For: | Compagnoni S, Bruno EM, Madonia G, Cannizzaro M, Madonia S. Direct antiviral agents in hepatitis C virus related liver disease: Don’t count the chickens before they’re hatched. World J Gastroenterol 2021; 27(21): 2771-2783 [PMID: PMC8173378 DOI: 10.3748/wjg.v27.i21.2771] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v27/i21/2771.htm |
Number | Citing Articles |
1 |
Hans Helmut Niller, Janos Minarovits. Epigenetics in Human Disease. 2024; : 779 doi: 10.1016/B978-0-443-21863-7.00006-8
|
2 |
Reham Hammad, Reda Badr Aglan, Shaymaa A. Mohammed, Eman Abu-elnasr Awad, Marwa A. Elsaid, Hanan M. Bedair, Seham K. Khirala, Mohamed A Selim, Asmaa A. Abo Elqasem, Areej Rushdi, Mohamed Ali, Omaima I. Abo-Elkheir, Eman F. Sanad, Nadia M. Hamdy. Cytotoxic T Cell Expression of Leukocyte-Associated Immunoglobulin-Like Receptor-1 (LAIR-1) in Viral Hepatitis C-Mediated Hepatocellular Carcinoma. International Journal of Molecular Sciences 2022; 23(20): 12541 doi: 10.3390/ijms232012541
|
3 |
Zuzana Macek Jilkova, Komal Saleem, Samia Afzal, Thomas Decaens. Predictive Factors for Hepatocellular Carcinoma Development after Direct-Acting Antiviral Treatment of HCV. Livers 2021; 1(4): 313 doi: 10.3390/livers1040024
|
4 |
Jui-Ting Hsu, Ping-I Hsu, Chang-Bih Shie, Seng-Kee Chuah, I-Ting Wu, Wen-Wei Huang, Sheng-Yeh Tang, Kun-Feng Tsai, Li-Fu Kuo, Supratip Ghose, Jui-Che Hsu, Chih-An Shih. Comparison of the Efficacies of Direct-Acting Antiviral Treatment for HCV Infection in People Who Inject Drugs and Non-Drug Users. Medicina 2022; 58(3): 436 doi: 10.3390/medicina58030436
|
5 |
Silvia Espina Cadena, Diego Casas Deza, Belén Julián Gomara, Cristina Victoria Borao Laguna, Olivia Sierra Gabarda, Luis Javier Lamuela Calvo, Sara Lorente, Trinidad Serrano, José Miguel Arbonés Mainar, Vanesa Bernal Monterde. Screening and risk of hepatocellular carcinoma in patients with advanced fibrosis after hepatitis C virus eradication. Revista Española de Enfermedades Digestivas 2024; doi: 10.17235/reed.2024.9945/2023
|